Are you Dr. Fenton?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 43 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6400 Arlington Blvd Ste 940
Falls Church, VA 22042Phone+1 240-447-2512Fax+1 703-241-7723- Is this information wrong?
Summary
- Dr. Robert Fenton, MD is an oncologist in Falls Church, Virginia. He is currently licensed to practice medicine in Maryland.
Education & Training
Brigham and Women's HospitalResidency, Internal Medicine, 1987 - 1989- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1985 - 1987
- Brigham and Women's HospitalResidency, Internal Medicine, 1983 - 1985
New York University School of MedicineClass of 1983
Certifications & Licensure
MD State Medical License 1989 - 2012
Publications & Presentations
PubMed
- 172 citationsNeurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature.Ashraf Badros, Olga Goloubeva, Jay S. Dalal, Ilyas Can, Jennifer Thompson, Aaron P. Rapoport, Meyer R. Heyman, Gorgon Akpek, Robert G. Fenton> ;Cancer. 2007 Sep 1
- 30 citationsPhase I trial of first-line bortezomib/thalidomide plus chemotherapy for induction and stem cell mobilization in patients with multiple myeloma.Ashraf Badros, Olga Goloubeva, Robert G. Fenton, Aaron P. Rapoport, Gorgun Akpek, Carolynn Harris, Kathleen Ruehle, Sandra Westphal> ;Clinical Lymphoma & Myeloma. 2006 Nov 1
- 6 citationsFlavopiridol in patients with relapsed or refractory multiple myeloma: a phase 2 trial with clinical and pharmacodynamic end-points.Angela Dispenzieri, Morie A Gertz, Martha Q Lacy, Susan M Geyer, Tom R Fitch, Robert G Fenton, Rafael Fonseca, Crescent R Isham, Steven C Ziesmer, Charles Erlichman, K...> ;Haematologica. 2006 Mar 1
- Join now to see all
Press Mentions
- Urine Concentration Ability Is Reduced to the Same Degree in Adult Dominant Polycystic Kidney Disease Compared with Other Chronic Kidney Diseases in the Same CKD-Stage and Lower THAN in Healthy Control Subjects - a CASE Control StudyAugust 31st, 2020
